Following its successful Phase 2 trial AnnJi Pharmaceutical is now one step closer to launching its Phase 3 trial in the United States.  Although it is early days, fingers are firmly crossed at KD-UK that a meaningful treatment for Kennedy’s Disease may be within reach.

Please CLICK HERE to see the full statement from AnnJi.